1-15 of 15
leukemia, lymphocytic, acute, childhood
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting pediatric leukemia-propagating cells with anti-CD200 antibody therapy

Paraskevi Diamanti, Charlotte V. Cox, Benjamin C. Ede, Robert A. Uger, John P. Moppett, Allison Blair
Journal: Blood Advances
Blood Adv (2021) 5 (18): 3694–3708.
https://doi.org/10.1182/bloodadvances.2020003534
Published: 2021
Includes: Supplemental data
Journal Articles

Pasquini MC, Hu Z-H, Curran K, et al. Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma. Blood Adv. 2020;4(21):5414-5424.

Journal: Blood Advances
Blood Adv (2021) 5 (4): 1136.
https://doi.org/10.1182/bloodadvances.2021004265
Published: 2021
Journal Articles

Brown LM, Lonsdale A, Zhu A, et al. The application of RNA sequencing for the diagnosis and genomic classification of pediatric acute lymphoblastic leukemia. Blood Adv. 2020;4(5):930-942.

Journal: Blood Advances
Blood Adv (2020) 4 (7): 1217.
https://doi.org/10.1182/bloodadvances.2020001859
Published: 2020
Journal Articles

The application of RNA sequencing for the diagnosis and genomic classification of pediatric acute lymphoblastic leukemia

Lauren M. Brown, Andrew Lonsdale, Andrea Zhu, Nadia M. Davidson, Breon Schmidt, Anthony Hawkins, Elise Wallach, Michelle Martin, Francoise M. Mechinaud, Seong Lin Khaw, Ray C. Bartolo, Louise E. A. Ludlow, Jackie Challis, Ian Brooks, Vida Petrovic, Nicola C. Venn, Rosemary Sutton, Ian J. Majewski, Alicia Oshlack, Paul G. Ekert
Journal: Blood Advances
Blood Adv (2020) 4 (5): 930–942.
https://doi.org/10.1182/bloodadvances.2019001008
Published: 2020
Includes: Supplemental data
Journal Articles

Results of CoALL 07-03 study childhood ALL based on combined risk assessment by in vivo and in vitro pharmacosensitivity

Clinical Trials & Observations
Franziska Schramm, Udo zur Stadt, Martin Zimmermann, Norbert Jorch, Arnulf Pekrun, Arndt Borkhardt, Thomas Imschweiler, Holger Christiansen, Jörg Faber, Irene Schmid, Tobias Feuchtinger, Gerhard Beron, Monique L. den Boer, Rob Pieters, Martin A. Horstmann, Gritta E. Janka-Schaub, Gabriele Escherich
Journal: Blood Advances
Blood Adv (2019) 3 (22): 3688–3699.
https://doi.org/10.1182/bloodadvances.2019000576
Published: 2019
Includes: Supplemental data
Journal Articles

More precisely defining risk peri-HCT in pediatric ALL: pre- vs post-MRD measures, serial positivity, and risk modeling

Peter Bader, Emilia Salzmann-Manrique, Adriana Balduzzi, Jean-Hugues Dalle, Ann E. Woolfrey, Merav Bar, Michael R. Verneris, Michael J. Borowitz, Nirali N. Shah, Nathan Gossai, Peter J. Shaw, Allen R. Chen, Kirk R. Schultz, Hermann Kreyenberg, Lucia Di Maio, Gianni Cazzaniga, Cornelia Eckert, Vincent H. J. van der Velden, Rosemary Sutton, Arjan Lankester, Christina Peters, Thomas E. Klingebiel, Andre M. Willasch, Stephan A. Grupp, Michael A. Pulsipher
Journal: Blood Advances
Blood Adv (2019) 3 (21): 3393–3405.
https://doi.org/10.1182/bloodadvances.2019000449
Published: 2019
Includes: Supplemental data
Journal Articles

Pediatric ALL relapses after allo-SCT show high individuality, clonal dynamics, selective pressure, and druggable targets

Jessica I. Hoell, Sebastian Ginzel, Michaela Kuhlen, Andreas Kloetgen, Michael Gombert, Ute Fischer, Daniel Hein, Salih Demir, Martin Stanulla, Martin Schrappe, Udo zur Stadt, Peter Bader, Florian Babor, Friedhelm Schuster, Brigitte Strahm, Julia Alten, Anja Moericke, Gabriele Escherich, Arend von Stackelberg, Ralf Thiele, Alice C. McHardy, Christina Peters, Beat Bornhauser, Jean-Pierre Bourquin, Stefan Krause, Juergen Enczmann, Lüder Hinrich Meyer, Cornelia Eckert, Arndt Borkhardt, Roland Meisel
Journal: Blood Advances
Blood Adv (2019) 3 (20): 3143–3156.
https://doi.org/10.1182/bloodadvances.2019000051
Published: 2019
Includes: Supplemental data
Journal Articles

Predisposition to childhood acute lymphoblastic leukemia caused by a constitutional translocation disrupting ETV6

Tekla Järviaho, Benedicte Bang, Vasilios Zachariadis, Fulya Taylan, Jukka Moilanen, Merja Möttönen, C. I. Edvard Smith, Arja Harila-Saari, Riitta Niinimäki, Ann Nordgren
Journal: Blood Advances
Blood Adv (2019) 3 (18): 2722–2731.
https://doi.org/10.1182/bloodadvances.2018028795
Published: 2019
Includes: Supplemental data
Journal Articles

Validation of the United Kingdom copy-number alteration classifier in 3239 children with B-cell precursor ALL

Clinical Trials & Observations
Lina Hamadeh, Amir Enshaei, Claire Schwab, Cristina N. Alonso, Andishe Attarbaschi, Gisela Barbany, Monique L. den Boer, Judith M. Boer, Marcin Braun, Luciano Dalla Pozza, Sarah Elitzur, Mariana Emerenciano, Larisa Fechina, Maria Sara Felice, Eva Fronkova, Irén Haltrich, Mats M. Heyman, Keizo Horibe, Toshihiko Imamura, Marta Jeison, Gábor Kovács, Roland P. Kuiper, Wojciech Mlynarski, Karin Nebral, Ingegerd Ivanov Öfverholm, Agata Pastorczak, Rob Pieters, Henriett Piko, Maria S. Pombo-de-Oliveira, Patricia Rubio, Sabine Strehl, Jan Stary, Rosemary Sutton, Jan Trka, Grigory Tsaur, Nicola Venn, Ajay Vora, Mio Yano, Christine J. Harrison, Anthony V. Moorman
Journal: Blood Advances
Blood Adv (2019) 3 (2): 148–157.
https://doi.org/10.1182/bloodadvances.2018025718
Published: 2019
Includes: Supplemental data
Journal Articles

Treating childhood acute lymphoblastic leukemia in a country with no pediatric hematologist/oncologist: a Belize/Mérida joint venture

Ellsworth Grant, Pablo González-Montalvo, Francisco Pantoja-Guillén, Gabriela Escamilla
Journal: Blood Advances
Blood Adv (2018) 2 (Supplement_1): 67–68.
https://doi.org/10.1182/bloodadvances.2018GS112665
Published: 2018
Journal Articles

Combined inhibition of receptor tyrosine and p21-activated kinases as a therapeutic strategy in childhood ALL

Clinical Trials & Observations
Ina-Katrin Siekmann, Kevin Dierck, Sebastian Prall, Marianne Klokow, Julia Strauss, Sophia Buhs, Antonina Wrzeszcz, Michael Bockmayr, Florian Beck, Magdalena Trochimiuk, Kristina Gottschling, Victoria Martens, Melissa Khosh-Naucke, Helwe Gerull, Jürgen Müller, Lena Behrmann, Martin Blohm, René P. Zahedi, Irmela Jeremias, Albert Sickmann, Peter Nollau, Martin A. Horstmann
Journal: Blood Advances
Blood Adv (2018) 2 (19): 2554–2567.
https://doi.org/10.1182/bloodadvances.2018020693
Published: 2018
Includes: Supplemental data
Journal Articles

Patterns of care and outcomes in adolescent and young adult acute lymphoblastic leukemia: a population-based study

Clinical Trials & Observations
Lori Muffly, Elysia Alvarez, Daphne Lichtensztajn, Renata Abrahão, Scarlett Lin Gomez, Theresa Keegan
Journal: Blood Advances
Blood Adv (2018) 2 (8): 895–903.
https://doi.org/10.1182/bloodadvances.2017014944
Published: 2018
Includes: Supplemental data
Journal Articles

Mutational dynamics of early and late relapsed childhood ALL: rapid clonal expansion and long-term dormancy

Clinical Trials & Observations
Jean-François Spinella, Chantal Richer, Pauline Cassart, Manon Ouimet, Jasmine Healy, Daniel Sinnett
Journal: Blood Advances
Blood Adv (2018) 2 (3): 177–188.
https://doi.org/10.1182/bloodadvances.2017011510
Published: 2018
Includes: Supplemental data
Journal Articles

Capacity-building initiative to improve clinical outcomes in pediatric acute lymphoblastic leukemia in the US-Mexico border region

Laura Nuño-Vázquez, Rebeca Rivera-Gomez, Mario Ornelas-Sánchez, Raul C. Ribeiro, William Roberts, Paula Aristizabal
Journal: Blood Advances
Blood Adv (2017) 1 (Suppl): 70–73.
https://doi.org/10.1182/bloodadvances.2017GS101484
Published: 2017
Journal Articles

Improved outcomes in pediatric acute lymphoblastic leukemia (ALL) with adapted treatment intensity: the use of SIOP-PODC ALL regimen 2 in a resource-limited tertiary referral setting

Joliza Patricia Caneba, Jochrys Estanislao, Pamela Fajardo, Catherine Lam, Ana Patricia Alcasabas
Journal: Blood Advances
Blood Adv (2017) 1 (Suppl): 46–48.
https://doi.org/10.1182/bloodadvances.2017GS102619
Published: 2017